Arkolith/Insider Trading/RGNX/Form 4

Mills Kenneth T.

DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Jan 29, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2026Tax withholding(F)222K$13.41$3.0M486K
Jan 27, 2026Option exercise(M)225K$13.09$2.9M708K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2026Option exercise(M)225K—$0225K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001652824-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML